Humacyte

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.81-$9.97
Market Cap
$482.5M
Shares Short
24M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
-$77.3M
Diluted EPS
-$1.34

News

See more

Yahoo Finance • 30 days ago

HUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Yahoo Finance • last month

DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Yahoo Finance • last month

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting

Yahoo Finance • last month

HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA

About

CEO
Dr. Laura E. Niklason M.D., Ph.D.
CFO
Mr. Dale A. Sander
Address
2525 East North Carolina Highway 54, Durham, NC, United States, 27713
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
183